Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: Potential synergistic effects on prognosis

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1169-1176

  Xu, Hong Ji ^a,c   Cagle, Philip T ^b   Hu, Shi Xue ^a   Li, Jian ^b,d   Benedict, William F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PROTEIN P53;

ADENOCARCINOMA; ARTICLE; CANCER SURVIVAL; DRUG EFFECT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETINOBLASTOMA PROTEIN; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029992389     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Quinlan, D. C., Davidson, A G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
2. Xu, H-J., Quinlan, D. C., Davidson, A. G., Hu, S-X., Summers, C L., Li, J., and Benedict, W. F. Altered retinoblastoma protein expression and prognosis in early-stage non-small cell lung carcinoma. J. Natl. Cancer Inst., 86: 695-699, 1994
3. Ebina, M., Steinberg, S. M., Mulshine, J. L., and Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496-2503, 1994.
4. McLaren, R., Kuzu, L., Dunmil, M., Harris, A., Lane, D , and Gatter, K. C. The Relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735-738, 1992.
5. Mitsudomi, T , Steinberg, S M., Nau, M M., Carbone, D., D'Amico, D., Bodner, S., Oie, H. J. K., Linnoila, R I., Mulshine, J. L., Minna, J D., and Gazlar, A. F. p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
6. Rcissmann, P. T., Koga, H., Takahashi, R., Figlin, R. A., Holmes, E. C., Piantadosi, S., Cordon Cardo, C., and Slamon, D. J. Inactivation of the retinoblastoma susceptibility gene in non-small lung cancer Oncogene, 8: 1913-1919, 1993
7. Carbone, D. P., Mitsudomi, T., Chiba, I., Piantadosi. S., Rusch, V., Nowak, J. A., McIntire, D., Slamon, D., Gazdar, A., and Minna, J. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest, 106 (Suppl. 6). 377S-381S, 1994.
8. Lee, J. S., Yoon, A., Kalapurakal, S. K., Ro, J. Y., Lee, J J., Tu, N., Hittelman, W. N., and Hong, W. K. Expression of p53 oncoprotein in non-small cell Lung cancer: a favorable prognostic factor. J. Clin. Oncol., 13: 1893-1903, 1995.
9. Xu, H-J., Hu, S-X., Cagle, P. T., Moore, G. E., and Benedict, W. F. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res., 51: 2735-2739, 1991.
10. Xu, H-J. Altered retinoblastoma (RB) protein expression in human malignancies. Adv. Anat. Pathol., 2: 213-226, 1995.
11. Xu, H-J., Cairns, P., Hu, S-X., Knowles, M A., and Benedict, W. F. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer, 53: 781-784, 1993.
12. Zhang, X., Xu, H-J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S-X., Benedict, W. F., and Sekiya, T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res., 54: 4177-4182, 1994.
13. Bodner, S. M., Minna, J. D., Jensen, S. M., D'Amico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchlagen, D. L., Nau, M. M., Gazdar, A. F., and Linnoila, R. J. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7: 743-749, 1992.
14. Guinee, D. G., Jr., Travis, W. D., Trivers, G. E., De Benedetti, V. M. G., Cawley, H , Welsh, J. A., Bennett, W. P., Jett, J., Colby, T. V., Tazelaar, H., Abbondanzo, S. L., Pairolero, P., Trastck, V., Caporaso, N. E., Liotta, L. A., and Harris, C. C. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis (Lond.), 16: 993-1002, 1995.
15. Geradts, J., Hu, S-X., Lincoln, C. E., Benedict, W. F., and Xu, H-J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer, 58: 161-167, 1994.
16. Cattoretti, G., Becker, M. H. G , Key, G., Duchrow, M., Schulter, C., Galle, J., and Gerdes, J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB and MIB 3) detect proliferating cells in microwave-processed, formalin-fixed paraffin sections. J. Pathol., 168: 357-363, 1992.
17. Cattoretti, G., Pileri, S., Parraviccini, C., Becker, M. H. G., Poggi, S., Biufulco, C., Key, G., D'Amato, L., Sabattini, E., Feudale, E., Reynolds, F., Gerdes, J., and Rilke, F. Antigen unmasking of formalin-fixed, paraffin-embedded tissue sections. J. Pathol., 171: 83-98, 1993.
18. Xu, H-J., Hu, S-X , Hashimoto, T., Takahashi, R., and Benedict, W. F. The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene, 4: 807-812, 1989.
19. 1 cells: correlation to changes in total RB protein level. Oncogene, 6: 1139-1146, 1991.
20. Cordon-Cardo, C., and Richon, V. M. Expression of the retinoblastoma protein is regulated in normal human tissues. Am. J. Pathol., 144. 500-510, 1994.
21. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am Stat. Assoc., 53, 457-481, 1958.
22. Mantel, N., and Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl. Cancer Inst., 22: 719-748, 1959.
23. Cox, D. R. Regression models and life tables J. R. Stat. Soc., 34: 187-220, 1972.
24. Esrig, D., Shi, S-R., Bochner, B. H., Nichols, P. W., Chen, S-C., Yang, C., Jones, P., Skinner, D. G., Cote, R. J., Xu, H-J., and Benedict, W. F. Prognostic importance of p53 and Rb alterations in transitional cell carcinoma of the bladder (Abstract) J. Urol., 153: 362A, 1995.
25. Battifora, H. P53 immunohistochemistry: a word of caution Hum. Pathol., 25: 435-437, 1994.
26. Dalquen, P., Sauter, G., Torhorst, J., Schultheiss, E., Jordan, P., Lehmann, S., Stulz, P., Mihatsch, M. J., and Gudat, F. Nuclear p53 Overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J. Pathol., 178: 53-58, 1996.
27. Harpole, D. H., Jr., Herndon, J. E., II, Wolfe, W. G., Iglehart, J. D., and Marks, J. R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res., 55: 51-56, 1995.